Search for a command to run...
Advanced Enzyme Technologies Ltd. demonstrates solid growth metrics and profitability compared to its peers, but has a relatively high PE ratio. While it shows good revenue growth, its valuation metrics suggest it may not be the most attractive investment compared to others in the sector. Companies like Dr. Reddy's Laboratories and Cipla present stronger overall financial profiles, suggesting they could be better investment choices.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
ADVENZYMES | ₹338.70 | ₹3,789.41Cr | 37.00 | 14.78% | 0.02 |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |